Earnings Per Share, Basic in USD/shares of Cidara Therapeutics, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cidara Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2018 to Q3 2025.
  • Cidara Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -3.1 USD/shares, a 26.5% decline year-over-year.
  • Cidara Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -8 USD/shares, a 66.9% increase year-over-year.
  • Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -26.8 USD/shares, a 410% decline from 2023.
  • Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -5.25 USD/shares, a 994% decline from 2022.
  • Cidara Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -0.48 USD/shares, a 40.7% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Cidara Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$8 -$3 -$1 -26.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$7 -$2 +$18.30 +91.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$26 -$2 +$0.62 +27.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$26 -$2 -$1 -151% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 -$25 -$2 $0 -21.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$25 -$20 -$17 -562% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$8 -$2 -$3 -480% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$5 -$1 -$1 -479% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 -$4 -$2 -$2 -1363% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$2 -$3 -$3 -1213% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $0 $0.60 +$0.87 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $0 $0 +$0.09 +39.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-22
Q3 2022 $0 $0.16 +$0.53 Jul 1, 2022 Sep 30, 2022 10-K 2024-04-22
Q2 2022 -$1 $0 $0 -228% Apr 1, 2022 Jun 30, 2022 10-K 2024-04-22
Q1 2022 $0 $0 +$0.12 +30.8% Jan 1, 2022 Mar 31, 2022 10-K 2024-04-22
Q4 2021 $0 $0 +$0.25 +52.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$1 $0 +$0.04 +9.76% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1 $0.18 +$0.63 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1 $0 +$0.07 +15.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$1 $0 $0 -14.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$1 $0 $0 -613% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$1 $0 +$0.02 +4.26% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$1 $0 +$0.12 +20.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$1 $0 Oct 1, 2019 Dec 31, 2019 10-K 2020-03-04
Q3 2019 $0.08 +$0.57 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$1 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08

Cidara Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$27 -$22 -410% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$5 -$5 -994% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $0 +$0.33 +40.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-22
2021 -$1 +$0.99 +55% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 -$2 $0 -31.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 -$1 Jan 1, 2019 Dec 31, 2019 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.